Basagine®

Basagine®

Therapeutic Segment: Anti-Diabetic

Generic Name: Insulin glargine rDNA

Indication:

For once daily subcutaneous administration for the treatment of:

  • Adult and Pediatric patients with Type I Diabetes Mellitus.
  • Adult patients with Type II Diabetes Mellitus who require basal (long-acting) insulin for the control of
    hyperglycemia.

Available as:

Injectables
  • 100IU/ML